APA Alıntı

Zenz, T., Gribben, J. G., Hallek, M., Döhner, H., Keating, M. J., & Stilgenbauer, S. (2012). Risk categories and refractory CLL in the era of chemoimmunotherapy. Blood.

Chicago Stili Alıntı

Zenz, Thorsten, John G. Gribben, Michael Hallek, Hartmut Döhner, Michael J. Keating, ve Stephan Stilgenbauer. "Risk Categories and Refractory CLL in the Era of Chemoimmunotherapy." Blood 2012.

MLA Alıntı

Zenz, Thorsten, et al. "Risk Categories and Refractory CLL in the Era of Chemoimmunotherapy." Blood 2012.